These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 6765966)
21. Studies on the effect of specific antisera on the metabolism of cellular antigens. I. Isolation of thymus leukemia antigens. Yu A; Cohen EP J Immunol; 1974 Apr; 112(4):1285-95. PubMed ID: 4815091 [No Abstract] [Full Text] [Related]
22. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines. Fuji H Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299 [TBL] [Abstract][Full Text] [Related]
23. Purification and partial characterization of a murine mammary tumor-associated antigen. Chattopadhyay J; Chatterjee R; Chattopadhyay U; Chowdhury JR Gan; 1984 Apr; 75(4):334-41. PubMed ID: 6329884 [TBL] [Abstract][Full Text] [Related]
24. Preparation and characterization of the monospecific antiserum directed to the ninth component of human complement (C9). Kawachi-Takahashi S; Tanaka K; Takahashi M Jpn J Exp Med; 1974 Jun; 44(3):283-90. PubMed ID: 4215913 [No Abstract] [Full Text] [Related]
25. Purification, partial characterization, and clinical evaluation of an adenocarcinoma-associated antigen. Pinto VB; Gelder FB; Morris DM Cancer Res; 1986 Dec; 46(12 Pt 1):6520-4. PubMed ID: 3536083 [TBL] [Abstract][Full Text] [Related]
26. Water-soluble P-815 mastocytoma membrane antigens: separation of tumour-associated antigens from histocompatibility antigens. Clemetson KJ; Bertschmann M; Widmer S; Lüscher EF Immunochemistry; 1976 May; 13(5):383-8. PubMed ID: 820631 [No Abstract] [Full Text] [Related]
27. The stimulation of a T cell response in the syngeneic host by the P-815 mastocytoma cell and the isolation of a tumor-associated antigen which has some H-2 antigen characteristics. Bertschmann M; Clemetson KJ; Lüscher EF Adv Exp Med Biol; 1979; 114():751-6. PubMed ID: 111488 [TBL] [Abstract][Full Text] [Related]
28. Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors. Liu B; Podack ER; Allison JP; Malek TR J Immunol; 1996 Feb; 156(3):1117-25. PubMed ID: 8557987 [TBL] [Abstract][Full Text] [Related]
29. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model. Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185 [TBL] [Abstract][Full Text] [Related]
30. Host B7-1 and B7-2 costimulatory molecules contribute to the eradication of B7-1-transfected P815 tumor cells via a CD8+ T cell-dependent mechanism. La Motte RN; Sharpe AH; Bluestone JA; Mokyr MB J Immunol; 1999 Apr; 162(8):4817-23. PubMed ID: 10202025 [TBL] [Abstract][Full Text] [Related]
31. Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. Grohmann U; Silla S; Belladonna ML; Bianchi R; Orabona C; Puccetti P; Fioretti MC Cell Immunol; 1997 Nov; 181(2):109-19. PubMed ID: 9398398 [TBL] [Abstract][Full Text] [Related]
32. Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7. Nakajima A; Kodama T; Morimoto S; Azuma M; Takeda K; Oshima H; Yoshino S; Yagita H; Okumura K J Immunol; 1998 Aug; 161(4):1901-7. PubMed ID: 9712059 [TBL] [Abstract][Full Text] [Related]
33. Enhancement by IL-12 of the cytolytic T lymphocyte (CTL) response of mice immunized with tumor-specific peptides in an adjuvant containing QS21 and MPL. Silla S; Fallarino F; Boon T; Uyttenhove C Eur Cytokine Netw; 1999 Jun; 10(2):181-90. PubMed ID: 10400824 [TBL] [Abstract][Full Text] [Related]
34. Tumor-associated surface membrane antigens on CFUs: characterization using the fluorescent activated cell sorter. Hasthorpe S; Rogerson J Exp Hematol; 1982 Jan; 10(1):9-19. PubMed ID: 7060662 [TBL] [Abstract][Full Text] [Related]
35. B7-negative versus B7-positive P815 tumor: differential requirements for priming of an antitumor immune response in lymph nodes. Yang G; Mizuno MT; Hellström KE; Chen L J Immunol; 1997 Jan; 158(2):851-8. PubMed ID: 8993003 [TBL] [Abstract][Full Text] [Related]
36. The isolation and characterization of soluble murine H-2 alloantigens. DiPadua D; McKenzie IF; Russell PS Transplant Proc; 1973 Mar; 5(1):435-8. PubMed ID: 4572105 [No Abstract] [Full Text] [Related]
37. Tumour-associated antigens of the mouse P-815 mastocytoma cell: evidence for an antigen with H-2-like characteristics. Clemetson KJ; Bertschmann M; Lüscher EF Mol Immunol; 1981 Feb; 18(2):135-41. PubMed ID: 6167852 [No Abstract] [Full Text] [Related]
38. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice. Niederkorn J; Streilein JW; Shadduck JA Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):355-63. PubMed ID: 6782034 [TBL] [Abstract][Full Text] [Related]
39. Isolation of immunogenic and suppressogenic determinants of the nonimmunogenic YAC tumor and the change in its immunogenic repertoire after in vitro cultivation. Klein BY; Devens B; Deutsch O; Ahituv A; Frenkel S; Kobrin BJ; Naor D Transplant Proc; 1981 Mar; 13(1 Pt 2):790-7. PubMed ID: 6168075 [No Abstract] [Full Text] [Related]
40. Lectin-induced nonlethal adhesions between cytolytic T lymphocytes and antigenically unrecognizable tumor cells and nonspecific "triggering" of cytolysis. Parker WL; Martz E J Immunol; 1980 Jan; 124(1):25-35. PubMed ID: 6765968 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]